Toggle navigation
TWText.com
TWText.com
faq
Contact US
Follow US
#ConvalescentPlasma
Pramesh CS
cspramesh
I can't believe the @US_FDA Commissioner @SteveFDA announced that 35 out of 100 patients treated with #ConvalescentPlasma will benefit from it. This demonstrates either a lack of understanding of basic
Read more
SARS-CoV-19 Preprints
SARSCoV192
1/11 Analysis of humoral immune response in #COVID19 patients provides key insights for #ConvalescentPlasma therapy and #Vaccine research: https://www.medrxiv.org/content/10.1101/2020.03.30.20047365v1 2/11 A pseudotyped-lentiviral-vector-based neutra
Read more
Neil Floch MD
NeilFlochMD
After listening to a webinar from 5 Chinese #doctors in Wuhan, China who are in the middle of their outbreak - the following can be learned. 1/ Treatment: Much of
Read more
Pramesh CS
cspramesh
I know the #COVID-19 numbers in India are not looking good, but here are my (not so) random thoughts on it We have 2 options – one, rant & rail
Read more
Nayyar Ahmed, PhD
Muslim_Scientst
#Coronavirus Thread Part 3 Dr. Anthony Fauci announced that "antibody test is coming in a week or so". What does #antibody mean?#Antibodies are proteins in the immune system that are
Read more
Dena Grayson, MD, PhD
DrDenaGrayson
BREAKING: Good news! Preliminary study of 10 patients with severe #COVID19 shows that after 1 dose of convalescent plasma:Virus disappeared in blood in 7 daysClinical symptoms rapidly improved within 3
Read more
Ruminda
Rumindahg
Thread1 month since the diagnosis of the 1st #lka #Covid_19 Patient. Webinar by @CCP Dr. Ananda Wijewickrama, Dr. Damayanthi Idampitiya & Dr. Eranga Narangoda.Physicians at the National Institute of Infectious
Read more
Pramesh CS
cspramesh
I’ve been watching with increasing concern at the trend of new daily diagnoses of COVID-19 in India over the past two weeks. To me, this reflects general public mood which
Read more
Donna Young
DonnaYoungDC
The impact of the first companies getting #FDA emergency use authorization & unblinding studies expected to be among the topics debated over at today's #FDA #VRBPAC My Oct 20 story:
Read more